These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23338123)

  • 1. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.
    Luo G; Long J; Cui X; Xiao Z; Liu Z; Shi S; Liu L; Liu C; Xu J; Li M; Yu X
    Int J Oncol; 2013 Mar; 42(3):979-84. PubMed ID: 23338123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C; Huang T; Ding YC; Yu W; Wang Q; Meng B; Luo SX
    Int J Clin Exp Pathol; 2015; 8(6):6533-9. PubMed ID: 26261532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a unique mouse model for pancreatic cancer lymphatic metastasis.
    Long J; Luo G; Liu C; Cui X; Satoh K; Xiao Z; Zhang B; Xu J; Ni Q; Li M; Yu X
    Int J Oncol; 2012 Nov; 41(5):1662-8. PubMed ID: 22941445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a cancer stem cell-like side population derived from human pancreatic adenocarcinoma cells.
    Zhang SN; Huang FT; Huang YJ; Zhong W; Yu Z
    Tumori; 2010; 96(6):985-92. PubMed ID: 21388063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side population in the pancreatic cancer cell lines SW1990 and CFPAC-1 is enriched with cancer stem-like cells.
    Yao J; Cai HH; Wei JS; An Y; Ji ZL; Lu ZP; Wu JL; Chen P; Jiang KR; Dai CC; Qian ZY; Xu ZK; Miao Y
    Oncol Rep; 2010 May; 23(5):1375-82. PubMed ID: 20372854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.
    Mueller MT; Hermann PC; Witthauer J; Rubio-Viqueira B; Leicht SF; Huber S; Ellwart JW; Mustafa M; Bartenstein P; D'Haese JG; Schoenberg MH; Berger F; Jauch KW; Hidalgo M; Heeschen C
    Gastroenterology; 2009 Sep; 137(3):1102-13. PubMed ID: 19501590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
    Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
    Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.
    Fredebohm J; Boettcher M; Eisen C; Gaida MM; Heller A; Keleg S; Tost J; Greulich-Bode KM; Hotz-Wagenblatt A; Lathrop M; Giese NA; Hoheisel JD
    PLoS One; 2012; 7(11):e48503. PubMed ID: 23152778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine.
    Hayashi T; Ding Q; Kuwahata T; Maeda K; Miyazaki Y; Matsubara S; Obara T; Natsugoe S; Takao S
    Cancer Sci; 2012 May; 103(5):889-96. PubMed ID: 22320450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.
    García-Santos EP; Padilla-Valverde D; Villarejo-Campos P; Murillo-Lázaro C; Fernández-Grande E; Palomino-Muñoz T; Rodríguez-Martínez M; Amo-Salas M; Nuñez-Guerrero P; Sánchez-García S; Puerto-Puerto A; Martín-Fernández J
    Pancreatology; 2016; 16(4):632-9. PubMed ID: 27289344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH
    Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y; Xu W; Yang Y; Zhang Z
    Ann Clin Lab Sci; 2021 May; 51(3):310-320. PubMed ID: 34162560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.
    Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M
    Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.
    Matsubara S; Ding Q; Miyazaki Y; Kuwahata T; Tsukasa K; Takao S
    Sci Rep; 2013 Nov; 3():3230. PubMed ID: 24231729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.
    Shimizu K; Chiba S; Hori Y
    PLoS One; 2013; 8(11):e81283. PubMed ID: 24278411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.